IceCure Medical Statistics

Total Valuation

IceCure Medical has a market cap or net worth of $70.33 million. The enterprise value is $67.31 million.

Market Cap	70.33M
Enterprise Value	67.31M

Important Dates

The last earnings date was Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

IceCure Medical has 68.95 million shares outstanding. The number of shares has increased by 19.84% in one year.

Current Share Class	68.95M
Shares Outstanding	68.95M
Shares Change (YoY)	+19.84%
Shares Change (QoQ)	+1.79%
Owned by Insiders (%)	40.43%
Owned by Institutions (%)	0.36%
Float	41.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.51
Forward PS	18.22
PB Ratio	20.71
P/TBV Ratio	24.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	24.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.82.

Current Ratio	1.18
Quick Ratio	0.72
Debt / Equity	0.82
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -230.80% and return on invested capital (ROIC) is -120.95%.

Return on Equity (ROE)	-230.80%
Return on Assets (ROA)	-76.40%
Return on Invested Capital (ROIC)	-120.95%
Return on Capital Employed (ROCE)	-537.63%
Revenue Per Employee	$42,227
Profits Per Employee	-$236,061
Employee Count	66
Asset Turnover	0.21
Inventory Turnover	0.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +68.62% in the last 52 weeks. The beta is 2.48, so IceCure Medical's price volatility has been higher than the market average.

Beta (5Y)	2.48
52-Week Price Change	+68.62%
50-Day Moving Average	0.98
200-Day Moving Average	1.12
Relative Strength Index (RSI)	50.21
Average Volume (20 Days)	1,256,075

Short Selling Information

The latest short interest is 577,276, so 0.84% of the outstanding shares have been sold short.

Short Interest	577,276
Short Previous Month	1.15M
Short % of Shares Out	0.84%
Short % of Float	1.41%
Short Ratio (days to cover)	0.28

Income Statement

In the last 12 months, IceCure Medical had revenue of $2.79 million and -$15.58 million in losses. Loss per share was -$0.28.

Revenue	2.79M
Gross Profit	1.00M
Operating Income	-15.86M
Pretax Income	-15.58M
Net Income	-15.58M
EBITDA	-15.54M
EBIT	-15.86M
Loss Per Share	-$0.28

Full Income Statement

Balance Sheet

The company has $5.38 million in cash and $2.37 million in debt, giving a net cash position of $3.01 million or $0.04 per share.

Cash & Cash Equivalents	5.38M
Total Debt	2.37M
Net Cash	3.01M
Net Cash Per Share	$0.04
Equity (Book Value)	2.89M
Book Value Per Share	0.05
Working Capital	1.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.20 million and capital expenditures -$65,000, giving a free cash flow of -$14.26 million.

Operating Cash Flow	-14.20M
Capital Expenditures	-65,000
Free Cash Flow	-14.26M
FCF Per Share	-$0.21

Full Cash Flow Statement

Margins

Gross Margin	35.92%
Operating Margin	-569.07%
Pretax Margin	-559.02%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IceCure Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.84%
Shareholder Yield	-19.84%
Earnings Yield	-22.15%
FCF Yield	-20.28%

Analyst Forecast

The average price target for IceCure Medical is $2.00, which is 96.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$2.00
Price Target Difference	96.08%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	93.21%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IceCure Medical has an Altman Z-Score of -15.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.36
Piotroski F-Score	2